{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:31:03Z","timestamp":1790134263232,"version":"4.0.1"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["P01HL-78825"],"award-info":[{"award-number":["P01HL-78825"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["HT94252310109"],"award-info":[{"award-number":["HT94252310109"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The development of cell therapy as a widely available clinical option for ischaemic cardiomyopathy is hindered by the invasive nature of current cell delivery methods. Furthermore, the rapid disappearance of cells after transplantation provides a cogent rationale for using repeated cell doses, which, however, has not been done thus far in clinical trials because it is not feasible with invasive approaches. The goal of this translational study was to test the therapeutic utility of the intravenous route for cell delivery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Pigs with chronic ischaemic cardiomyopathy induced by myocardial infarction received one or three intravenous doses of allogeneic bone marrow mesenchymal stromal cells (MSCs) or placebo 35 days apart. Rigour guidelines, including blinding and randomization, were strictly followed. A comprehensive assessment of left ventricular (LV) function was conducted with three independent methods (echocardiography, magnetic resonance imaging, and haemodynamic studies). The results demonstrate that three doses of MSCs improved both load-dependent and independent indices of LV function and reduced myocardial hypertrophy and fibrosis; in contrast, one dose failed to produce most of these benefits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>To our knowledge, this is the first study to show that intravenous infusion of a cell product improves LV function and structure in a large animal model of chronic ischaemic cardiomyopathy and that repeated infusions are necessary to produce robust effects. This study, conducted in a clinically relevant model, supports a new therapeutic strategy based on repeated intravenous infusions of allogeneic MSCs and provides a foundation for a first-in-human trial testing this strategy in patients with chronic ischaemic cardiomyopathy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvae173","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T05:59:53Z","timestamp":1724047193000},"page":"1939-1952","source":"Crossref","is-referenced-by-count":17,"title":["Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-340X","authenticated-orcid":false,"given":"Xian-Liang","family":"Tang","sequence":"first","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Wysoczynski","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Gumpert","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Solanki","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Ruble","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Stowers","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Ou","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Tanveer","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Slezak","sequence":"additional","affiliation":[{"name":"Centre of Experimental Medicine, Institute for Heart Research , Bratislava ,","place":["Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K","family":"Kalra","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-8614","authenticated-orcid":false,"given":"Roberto","family":"Bolli","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology, University of Louisville , 550 S Jackson Street, ACB Bldg, 3rd Floor, Louisville, KY 40202"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"2024121018231697900_cvae173-B1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"2024121018231697900_cvae173-B2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","article-title":"Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure","volume":"81","author":"Perin","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B4","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"2024121018231697900_cvae173-B5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ejhf.2178","article-title":"A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial","volume":"23","author":"Bolli","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2024121018231697900_cvae173-B6","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","article-title":"Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"2024121018231697900_cvae173-B7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cvr\/cvab135","article-title":"Cell therapy in patients with heart failure: a comprehensive review and emerging concepts","volume":"118","author":"Bolli","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024121018231697900_cvae173-B8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","article-title":"New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types","volume":"123","author":"Wysoczynski","year":"2018","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11010-021-04283-2","article-title":"Effect of intravenous cell therapy in rats with old myocardial infarction","volume":"477","author":"Tang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"2024121018231697900_cvae173-B10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/CIRCRESAHA.116.305557","article-title":"\u201cString theory\u201d of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results","volume":"116","author":"Keith","year":"2015","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"2024121018231697900_cvae173-B13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.113.301720","article-title":"Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis","volume":"114","author":"Ismahil","year":"2014","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2024121018231697900_cvae173-B16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"2024121018231697900_cvae173-B17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B19","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2014current views","volume":"25","author":"Phinney","year":"2007","journal-title":"Stem Cells"},{"key":"2024121018231697900_cvae173-B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2024121018231697900_cvae173-B21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0301-472X(02)00820-2","article-title":"Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD\/SCID mice","volume":"30","author":"Noort","year":"2002","journal-title":"Exp Hematol"},{"key":"2024121018231697900_cvae173-B22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/rccm.201001-0126OC","article-title":"Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking","volume":"183","author":"Schweitzer","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121018231697900_cvae173-B23","doi-asserted-by":"crossref","first-page":"e96725","DOI":"10.1371\/journal.pone.0096725","article-title":"c-kit+ cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"},{"key":"2024121018231697900_cvae173-B24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.117.310710","article-title":"Repeated cell therapy: a paradigm shift whose time has come","volume":"120","author":"Bolli","year":"2017","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","article-title":"Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in ell therapy","volume":"119","author":"Tokita","year":"2016","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/eurheartj\/ehp342","article-title":"Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction","volume":"31","author":"Gavira","year":"2010","journal-title":"Eur Heart J"},{"key":"2024121018231697900_cvae173-B27","doi-asserted-by":"crossref","first-page":"e007400","DOI":"10.1161\/JAHA.117.007400","article-title":"Repeated administrations of cardiac progenitor cells are superior to a single administration of an equivalent cumulative dose","volume":"7","author":"Tang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024121018231697900_cvae173-B28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-017-0606-5","article-title":"Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction","volume":"112","author":"Guo","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2024121018231697900_cvae173-B29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12015-020-10063-0","article-title":"Comparison of one and three injections of cardiac progenitor cells in a murine model of chronic ischemic cardiomyopathy","volume":"17","author":"Guo","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"2024121018231697900_cvae173-B30","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms22063145","article-title":"Comparison of repeated doses of c-kit-positive cardiac cells versus a single equivalent combined dose in a murine model of chronic ischemic cardiomyopathy","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024121018231697900_cvae173-B31","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s11010-021-04077-6","article-title":"Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice","volume":"476","author":"Nong","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"2024121018231697900_cvae173-B32","first-page":"568","article-title":"The adult G\u00f6ttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies","volume":"58","author":"Schuleri","year":"2008","journal-title":"Comp Med"},{"key":"2024121018231697900_cvae173-B33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.270","article-title":"Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure","volume":"17","author":"Kadota","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2024121018231697900_cvae173-B34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2024121018231697900_cvae173-B35","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","article-title":"Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy","volume":"66","author":"Karantalis","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B36","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2017.09.036","article-title":"A combination of allogeneic stem cells promotes cardiac regeneration","volume":"70","author":"Natsumeda","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B37","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jacc.2009.01.056","article-title":"Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging","volume":"53","author":"Schuleri","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2024121018231697900_cvae173-B38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12968-017-0333-y","article-title":"Cardiovascular magnetic resonance myocardial feature tracking using a non-rigid, elastic image registration algorithm: assessment of variability in a real-life clinical setting","volume":"19","author":"Morais","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024121018231697900_cvae173-B39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1148\/rg.210174","article-title":"Myocardial strain evaluation with cardiovascular MRI: physics, principles, and clinical applications","volume":"42","author":"Rajiah","year":"2022","journal-title":"Radiographics"},{"key":"2024121018231697900_cvae173-B40","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1113\/expphysiol.2013.074179","article-title":"Admittance-based pressure\u2013volume loop measurements in a porcine model of chronic myocardial infarction","volume":"98","author":"Van Hout","year":"2013","journal-title":"Exp Physiol"},{"key":"2024121018231697900_cvae173-B41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.121.057641","article-title":"Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure","volume":"145","author":"Abouleisa","year":"2022","journal-title":"Circulation"},{"key":"2024121018231697900_cvae173-B42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","article-title":"Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year","volume":"118","author":"Tang","year":"2016","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.109.871905","article-title":"Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction","volume":"121","author":"Tang","year":"2010","journal-title":"Circulation"},{"key":"2024121018231697900_cvae173-B44","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s12015-023-10590-6","article-title":"Bone marrow and Wharton\u2019s jelly mesenchymal stromal cells are ineffective for myocardial repair in an immunodeficient rat model of chronic ischemic cardiomyopathy","volume":"19","author":"Tang","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"2024121018231697900_cvae173-B45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/gerona\/glx056","article-title":"Allogeneic human mesenchymal stem cell infusions for aging frailty","volume":"72","author":"Golpanian","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024121018231697900_cvae173-B46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/gerona\/glx137","article-title":"Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial","volume":"72","author":"Tompkins","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024121018231697900_cvae173-B47","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"2024121018231697900_cvae173-B48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCRESAHA.117.311565","article-title":"Translational research in cardiovascular repair: a call for a paradigm shift","volume":"122","author":"Chamuleau","year":"2018","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B50","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121018231697900_cvae173-B51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"key":"2024121018231697900_cvae173-B52","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00395-011-0221-9","article-title":"Mesenchymal stromal cells mediate a switch to alternatively activated monocytes\/macrophages after acute myocardial infarction","volume":"106","author":"Dayan","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"2024121018231697900_cvae173-B53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10753-007-9025-3","article-title":"Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction","volume":"30","author":"Guo","year":"2007","journal-title":"Inflammation"},{"key":"2024121018231697900_cvae173-B54","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously delivered mesenchymal stem cells systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy","volume":"120","author":"Luger","year":"2017","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2006.11.022","article-title":"Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size","volume":"122","author":"Boomsma","year":"2007","journal-title":"Int J Cardiol"},{"key":"2024121018231697900_cvae173-B56","doi-asserted-by":"crossref","first-page":"e2103697","DOI":"10.1002\/advs.202103697","article-title":"Irisin promotes cardiac homing of intravenously delivered MSCs and protects against ischemic heart injury","volume":"9","author":"Yan","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"2024121018231697900_cvae173-B57","doi-asserted-by":"crossref","first-page":"H2670","DOI":"10.1152\/ajpheart.01071.2003","article-title":"Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis","volume":"287","author":"Nagaya","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121018231697900_cvae173-B58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00395-005-0521-z","article-title":"Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction","volume":"100","author":"Ma","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"2024121018231697900_cvae173-B59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/rme.10.104","article-title":"Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model","volume":"6","author":"Wang","year":"2011","journal-title":"Regen Med"},{"key":"2024121018231697900_cvae173-B60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.scr.2011.06.003","article-title":"Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application","volume":"7","author":"van Dijk","year":"2011","journal-title":"Stem Cell Res"},{"key":"2024121018231697900_cvae173-B61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12659\/MSMBR.883737","article-title":"Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?","volume":"19","author":"Yang","year":"2013","journal-title":"Med Sci Monit Basic Res"},{"key":"2024121018231697900_cvae173-B62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11010-013-1894-1","article-title":"Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy","volume":"387","author":"Yu","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"2024121018231697900_cvae173-B63","first-page":"1058","article-title":"Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4","volume":"7","author":"Li","year":"2015","journal-title":"Am J Transl Res"},{"key":"2024121018231697900_cvae173-B64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pathophys.2016.04.002","article-title":"Experimental induction of reparative morphogenesis and adaptive reserves in the ischemic myocardium using multipotent mesenchymal bone marrow-derived stem cells","volume":"23","author":"Mykhaylichenko","year":"2016","journal-title":"Pathophysiology"},{"key":"2024121018231697900_cvae173-B65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.117.311648","article-title":"S1P\u2013S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction","volume":"122","author":"Yamada","year":"2018","journal-title":"Circ Res"},{"key":"2024121018231697900_cvae173-B66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijcard.2005.07.036","article-title":"Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties","volume":"111","author":"Price","year":"2006","journal-title":"Int J Cardiol"},{"key":"2024121018231697900_cvae173-B67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/scd.2006.0089","article-title":"Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart","volume":"16","author":"Krause","year":"2007","journal-title":"Stem Cells Dev"},{"key":"2024121018231697900_cvae173-B68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00395-008-0741-0","article-title":"Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction","volume":"103","author":"Halkos","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"2024121018231697900_cvae173-B69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14017430802100280","article-title":"Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium\u2014complicated by myocardial tumor formation","volume":"43","author":"Wolf","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"2024121018231697900_cvae173-B70","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1002\/ccd.25566","article-title":"Intravenous xenogeneic transplantation of human adipose-derived stem cells improves left ventricular function and microvascular integrity in swine myocardial infarction model","volume":"86","author":"Hong","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024121018231697900_cvae173-B71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-020-0800-8","article-title":"Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia\/reperfusion injury","volume":"115","author":"Wang","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"2024121018231697900_cvae173-B72","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcyt.2013.07.016","article-title":"Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction","volume":"16","author":"Richardson","year":"2014","journal-title":"Cytotherapy"},{"key":"2024121018231697900_cvae173-B73","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1253\/circj.70.1184","article-title":"Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction","volume":"70","author":"Premaratne","year":"2006","journal-title":"Circ J"},{"key":"2024121018231697900_cvae173-B74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.carpath.2010.06.007","article-title":"Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction","volume":"20","author":"Zhang","year":"2011","journal-title":"Cardiovasc Pathol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae173\/59076006\/cvae173.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae173\/60949768\/cvae173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae173\/60949768\/cvae173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:55:40Z","timestamp":1733856940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/15\/1939\/7737527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":74,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8,20]]},"published-print":{"date-parts":[[2024,12,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae173","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,8,20]]}}}